Stay updated on AAV Gene Therapy in CNGB3 Achromatopsia Clinical Trial
Sign up to get notified when there's something new on the AAV Gene Therapy in CNGB3 Achromatopsia Clinical Trial page.

Latest updates to the AAV Gene Therapy in CNGB3 Achromatopsia Clinical Trial page
- Check4 days agoChange DetectedA banner announces an NIH website transition and says some content may use “Super Intelligence” in place of “Artificial Intelligence” during the transition.SummaryDifference1%

- Check11 days agoChange DetectedThe ClinicalTrials.gov footer revision label changes from v3.7.1 to v3.7.2, while the study page continues to display a 403 error.SummaryDifference0.2%

- Check18 days agoChange DetectedThe footer revision identifier changes from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check32 days agoChange DetectedThe 403 error content and the Home link were removed, restoring direct access to the study details for NCT02599922 on ClinicalTrials.gov.SummaryDifference0.5%

- Check39 days agoChange DetectedThe page now displays a 403 Forbidden error screen with a minimal HTML structure, replacing the previous content such as sponsor and study details with an access-denied message.SummaryDifference19%

- Check60 days agoChange DetectedPage revision updated from v3.6.5 to v3.6.6, indicating a minor update to the site's versioning or rendering. This change does not alter study details, eligibility criteria, endpoints, or any data on the page.SummaryDifference0.1%

Stay in the know with updates to AAV Gene Therapy in CNGB3 Achromatopsia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AAV Gene Therapy in CNGB3 Achromatopsia Clinical Trial page.